AIMS: To establish the prevalence and incidence of type 1 and type 2 diabetes in people with an intellectual and developmental disability and determine their impact on health and well-being and to appraise the evidence available to inform good practice in diabetes management for people with intellectual and developmental disabilities. METHODS: We conducted separate searches of multiple databases (EMBASE, CINAHL, MEDLINE, PsycINFO, SCOPUS, Web of Science, PUBMED and Cochrane Library) to find relevant articles. RESULTS: A total of 13 studies were identified: 13 addressed the prevalence of diabetes in people with intellectual and developmental disability, three addressed the impact of diabetes on their health and well-being and three addressed the management of diabetes. The prevalence of diabetes in people with intellectual and developmental disability remains uncertain, and the incidence of diabetes in this group of people is unknown. There is some evidence to support the assertion that people with intellectual and developmental disability might be at greater risk of diabetes than the general population. Overall, the quality of the evidence on which to base prevention and management strategies is variable. CONCLUSIONS: There is a paucity of research focusing on the prevalence, incidence and impact of diabetes among people with intellectual and developmental disability. Further research is needed to inform policy and practice in this area and, in particular, work is needed to develop methodologies, evaluation tools, educational resources and diabetes care support services appropriate to the needs of people with intellectual and developmental disability.
AIMS: To establish the prevalence and incidence of type 1 and type 2 diabetes in people with an intellectual and developmental disability and determine their impact on health and well-being and to appraise the evidence available to inform good practice in diabetes management for people with intellectual and developmental disabilities. METHODS: We conducted separate searches of multiple databases (EMBASE, CINAHL, MEDLINE, PsycINFO, SCOPUS, Web of Science, PUBMED and Cochrane Library) to find relevant articles. RESULTS: A total of 13 studies were identified: 13 addressed the prevalence of diabetes in people with intellectual and developmental disability, three addressed the impact of diabetes on their health and well-being and three addressed the management of diabetes. The prevalence of diabetes in people with intellectual and developmental disability remains uncertain, and the incidence of diabetes in this group of people is unknown. There is some evidence to support the assertion that people with intellectual and developmental disability might be at greater risk of diabetes than the general population. Overall, the quality of the evidence on which to base prevention and management strategies is variable. CONCLUSIONS: There is a paucity of research focusing on the prevalence, incidence and impact of diabetes among people with intellectual and developmental disability. Further research is needed to inform policy and practice in this area and, in particular, work is needed to develop methodologies, evaluation tools, educational resources and diabetes care support services appropriate to the needs of people with intellectual and developmental disability.
Authors: Kelly R Stanek; Erin M Youngkin; Laura L Pyle; Jennifer K Raymond; Kimberly A Driscoll; Shideh Majidi Journal: Pediatr Diabetes Date: 2019-05-08 Impact factor: 4.866
Authors: Nanna Lindekilde; Stine H Scheuer; Femke Rutters; Lenette Knudsen; Mathias Lasgaard; Katrine H Rubin; Jan Erik Henriksen; Mika Kivimäki; Gregers S Andersen; Frans Pouwer Journal: Diabetologia Date: 2021-11-29 Impact factor: 10.122
Authors: Sanne H M Kremers; Sarah H Wild; Petra J M Elders; Joline W J Beulens; David J T Campbell; Frans Pouwer; Nanna Lindekilde; Maartje de Wit; Cathy Lloyd; Femke Rutters Journal: Diabetologia Date: 2022-06-22 Impact factor: 10.460
Authors: Sally-Ann Cooper; Angela Henderson; Deborah Kinnear; Daniel Mackay; Michael Fleming; Gillian S Smith; Laura Anne Hughes-McCormack; Ewelina Rydzewska; Kirsty Dunn; J P Pell; Craig Melville Journal: BMJ Open Date: 2022-05-13 Impact factor: 3.006
Authors: Milou van den Bemd; Maarten Cuypers; Erik W M A Bischoff; Marloes Heutmekers; Bianca Schalk; Geraline L Leusink Journal: J Appl Res Intellect Disabil Date: 2021-11-08
Authors: L D Bryant; A M Russell; R E A Walwyn; A J Farrin; A Wright-Hughes; E H Graham; D Nagi; A Stansfield; J Birtwistle; S Meer; R A Ajjan; A O House Journal: Diabet Med Date: 2017-10-08 Impact factor: 4.359
Authors: John L O'Dwyer; Amy M Russell; Louise D Bryant; Rebecca E A Walwyn; Alexandra M Wright-Hughes; Elizabeth H Graham; Judy M Wright; Shaista Meer; Jacqueline Birtwistle; Amanda J Farrin; Allan O House; Claire T Hulme Journal: Pilot Feasibility Stud Date: 2018-04-23